Huai-Jen Tsai | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Forensic Scientist

Prof. Dr. Huai-Jen Tsai | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Institute of Life Science, Fu-Jen Catholic University | Taiwan

Prof. Dr. Huai-Jen Tsai is a distinguished molecular biologist whose research spans developmental biology, marine biotechnology, and gene transgenesis in aquatic organisms, with a particular focus on zebrafish and other finfish models. He has pioneered innovative sperm-mediated and electroporation-based gene transfer systems, enabling highly efficient transgenesis in finfish and shellfish, and has significantly advanced understanding of growth hormone regulation, gonadotropins, rhodopsins, and muscle-specific transcription factors, thereby contributing to both vertebrate developmental biology and aquaculture applications. Prof. Dr. Huai-Jen Tsai’s work bridges fundamental molecular biology and applied biotechnology, investigating molecular mechanisms regulating embryonic development, stress responses, and neural regeneration, including studies on ENDOU-mediated translation regulation and the role of extracellular proteins in promoting neurite outgrowth and spinal cord repair. He has authored 162 documents indexed in Scopus, which have been cited over 5,174 times by 4,191 publications, and he holds an h-index of 36, reflecting the high impact and wide recognition of his contributions in the scientific community. Throughout his career, Prof. Dr. Huai-Jen Tsai has received numerous prestigious awards, including the MOST Outstanding Research Award, Y. Z. Hsu Technology Invention Award for a patented zebrafish gene fragment, and multiple NSC Outstanding Research Awards, and he has served as principal investigator on numerous funded research projects. In addition, he contributes extensively as a reviewer and editorial board member for international journals. His research continues to integrate molecular genetics, developmental studies, and biotechnological innovation, establishing him as a leading authority in aquatic molecular genetics, transgenic technologies, and regenerative biology, and underscoring his influential role in advancing both basic science and translational applications in vertebrate and aquatic systems.

Profiles: Scopus | ORCID

Featured Publications

  • Lee, H.-C., Huang, Y.-H., Hsieh, C.-C., Ke, Y.-N., & Tsai, H.-J. (2025). ENDOU-1-induced cytoplasmic HnRNPA3 recognizes m6A methylation on the upstream reading frame of human CHOP transcripts to achieve maximal CHOP translation. Preprint.

  • Lee, B.-C., Tsai, J.-C., Huang, Y.-H., Wang, C.-C., Lee, H.-C., & Tsai, H.-J. (2024). The 419th aspartic acid of neural membrane protein enolase 2 is a key residue involved in axonal growth of motor neurons mediated by interaction between enolase 2 receptor and extracellular Pgk1 ligand. International Journal of Molecular Sciences, 25(19), 10753.

  • Lee, H.-C., Chao, H.-T., Lee, S. Y.-H., Lin, C.-Y., & Tsai, H.-J. (2023). The upstream 1350~1250 nucleotide sequences of the human ENDOU-1 gene contain critical cis-elements responsible for upregulating its transcription during ER stress. International Journal of Molecular Sciences, 24(24), 17393.

  • Zeng, C.-W., & Tsai, H.-J. (2023). The promising role of a zebrafish model employed in neural regeneration following a spinal cord injury. International Journal of Molecular Sciences, 24(18), 13938.

  • Fu, C.-Y., Chen, H.-Y., Lin, C.-Y., Chen, S.-J., Sheu, J.-C., & Tsai, H.-J. (2023). Extracellular Pgk1 interacts with neural membrane protein enolase-2 to improve neurite outgrowth of motor neurons. Communications Biology, 6, 822.

Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Prof. Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Tehran Medical Sciences, Islamic Azad University | Iran

Professor Mehrdad Hashemi is a renowned scholar in Molecular and Medical Genetics whose pioneering research has made transformative contributions to predictive, preventive, and personalized medicine. His scientific work focuses on the discovery of diagnostic and therapeutic biomarkers particularly non-coding RNAs (lncRNAs and miRNAs) with profound implications for early disease detection, molecular targeting, and precision therapy. Prof. Mehrdad Hashemi has authored 372 peer-reviewed publications indexed in Scopus, accumulating over 6,826 citations from 6,242 documents, and achieving a remarkable h-index of 41. His research portfolio includes 299 ISI-indexed papers, 342 Scopus-indexed papers, and 258 PubMed articles, encompassing 119 Q1 and 82 Q2 journals. He has led or completed 14 major research projects, contributed to 95 industrial and academic collaborations, and maintained 110 international research partnerships with leading institutions across the USA, UK, Canada, China, Germany, Australia, and beyond. His scholarly output also includes 3 internationally published books and 1 patent. Ranked among the World’s Top 1% and 2% Scientists in both ESI (2024) and Stanford (2024–2025) global rankings, Prof. Mehrdad Hashemi’s groundbreaking studies on exosomes, nanomedicine, gene regulation, and cancer therapeutics have advanced global understanding of disease mechanisms and innovative treatment modalities. He also contributes extensively as an editorial board member, peer reviewer, and thought leader in the field of molecular diagnostics and translational genetics.

Profiles: Scopus | Google Scholar | ORCID | Staff Page

Featured Publications

  • Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., … & Hashemi, M. (2022). Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology, 15(1), 83. https://doi.org/10.1186/s13045-022-01296-0

  • Bolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., … & Sadat, S. M. (2014). Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Human Vaccines & Immunotherapeutics, 10(2), 321–332. https://doi.org/10.4161/hv.26796

  • Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., … & Hashemi, M. (2022). AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy, 146, 112563. https://doi.org/10.1016/j.biopha.2021.112563

  • Hashemi, M., Moosavi, M. S., Abed, H. M., Dehghani, M., Aalipour, M., Heydari, E. A., … & Mirzaei, S. (2022). Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research, 184, 106418. https://doi.org/10.1016/j.phrs.2022.106418

  • Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., Rezaei, S., Hejazi, E. S., … & Hashemi, M. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research, 182, 106311. https://doi.org/10.1016/j.phrs.2022.106311